explore -WSS

explore

author：Wikipedia 2025-10-01 00:58:18 - browse：5988

An illustrated portrait of Eli Lilly's David Ricks and Skovronsky – biotech and pharma coverage from STAT — Eli Lilly CEO David Ricks (left) and Chief Scientific Officer Daniel S. Skovronsky Molly Ferguson for STAT

The partnership that would shape Eli Lilly into one of the biggest success stories in the pharmaceutical industry began with conversations around a relatively minor acquisition.

At the time, David Ricks was running Lilly’s U.S. business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm. But what struck Ricks was not the company’s technology, for imaging Alzheimer’s plaques, but Avid’s CEO, Daniel S. Skovronsky.

“Dan’s different,” Ricks told STAT. “I had this sense immediately. Some people get in biotech for the cha-ching.” Skovronsky turned out to be a secret weapon. Within six months, Ricks had been promoted to run Lilly’s biomedicine unit and Skovronsky was working for him.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Bird flu: Don't repeat Covid's 'health versus the economy' framing

focus

WSS

Readers respond to H5N1 and livestock movements, and more

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Readout LOUD podcast: Live from STAT Breakthrough Summit West

With measles on the rise, a personal story of a devastating disease

Vertex non

explore

explore

Wikipedia

Medicare details structure of new drug price negotiation program

Micronoma's microbiome cancer diagnostic approach under fire

Walensky prepares to leave CDC — and Congress — behind

Micronoma's microbiome cancer diagnostic approach under fire

Dobbs anniversary: the lost opportunity of abortion as health care

Micronoma's microbiome cancer diagnostic approach under fire

Virginia high school admissions case could be legal follow

Mitch McConnell episode has important public health takeaway

Supreme Court strikes down use of affirmative action

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

hotspot

Criminal prosecution for violating HIPAA: an emerging threat

Trump indictment: Who are the 'co

Micronoma's microbiome cancer diagnostic approach under fire

HIV vaccine remains elusive. Immunologists keep trying new ideas

With measles on the rise, a personal story of a devastating disease

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

explore

focus

hotspot

knowledge